系統性紅斑狼瘡并發急性粒細胞白血病一例_West China Medical Journal

Authors：

 張夢云 , 青玉鳳 ,  周京國

Corresponding?author：

周京國, Email: jgzhou@nsmc.edu.cn

Keywords：

系統性紅斑狼瘡; 急性粒細胞白血病; 白血病

DOI：

10.7507/1002-0179.20140200

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 張夢云, 青玉鳳, 周京國. 系統性紅斑狼瘡并發急性粒細胞白血病一例. West China Medical Journal, 2014, 29(4): 665-666. doi: 10.7507/1002-0179.20140200 Copy

1.	Al Arfaj AS, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.[J] Lupus, 2009, 18(5):465-473.
2.	譚艷紅, 劉冬舟, 肖學呂, 等. 自身免疫性疾病合并惡性腫瘤17例分析[J]. 臨床和實驗醫學雜志, 2007, 6(3):41-42.
3.	Bernatsky S, Ramsey-Goldman R, Clarke AE. Malignancy in systemic lupus erythematosus:what have we learned?[J]. Best Pract Res Clin Rheumatol, 2009, 23(4):539-547.
4.	陳冬瑩, 王曉東, 詹鐘平, 等. 硫唑嘌呤治療系統性紅斑狼瘡的不良反應與硫嘌呤甲基轉移酶活性的關系[J]. 中山大學學報·醫學科學版, 2011, 32(6):777-780, 785.
5.	Anderson LA, Pfeiffer RM, Landgren O, et al. Risks of myeloid malignancies in patients with autoimmune conditions[J]. Br J Cancer, 2009, 100(5):822-828.
6.	Kittang AO, Hatfield K, Sand K, et al. The chemokine network in acute myelogenous leukemia:molecular mechanisms involved in leukemogenesis and therapeutic implications[J]. Curr Top Microbiol Immunol, 2010, 341:149-172.
7.	Hase K, Tani K, Shimizu T, et al. Increased CCR4 expression in active systemic lupus erythematosus[J]. J Leukoc Biol, 2001, 70(5):749-755.
8.	劉佳, 鐘璐, 朱堅軼, 等. 系統性紅斑狼瘡合并急性髓系白血病一例[J]. 白血病·淋巴瘤, 2012, 21(6):378-379.
9.	Ziakas PD, Giannouli S, Zintzaras E, et al. Lupus thrombocytopenia:clinical implications and prognostic significance[J]. Ann Rheum Dis, 2005, 64(9):1366-1369.

1. Al Arfaj AS, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.[J] Lupus, 2009, 18(5):465-473.
2. 譚艷紅, 劉冬舟, 肖學呂, 等. 自身免疫性疾病合并惡性腫瘤17例分析[J]. 臨床和實驗醫學雜志, 2007, 6(3):41-42.
3. Bernatsky S, Ramsey-Goldman R, Clarke AE. Malignancy in systemic lupus erythematosus:what have we learned?[J]. Best Pract Res Clin Rheumatol, 2009, 23(4):539-547.
4. 陳冬瑩, 王曉東, 詹鐘平, 等. 硫唑嘌呤治療系統性紅斑狼瘡的不良反應與硫嘌呤甲基轉移酶活性的關系[J]. 中山大學學報·醫學科學版, 2011, 32(6):777-780, 785.
5. Anderson LA, Pfeiffer RM, Landgren O, et al. Risks of myeloid malignancies in patients with autoimmune conditions[J]. Br J Cancer, 2009, 100(5):822-828.
6. Kittang AO, Hatfield K, Sand K, et al. The chemokine network in acute myelogenous leukemia:molecular mechanisms involved in leukemogenesis and therapeutic implications[J]. Curr Top Microbiol Immunol, 2010, 341:149-172.
7. Hase K, Tani K, Shimizu T, et al. Increased CCR4 expression in active systemic lupus erythematosus[J]. J Leukoc Biol, 2001, 70(5):749-755.
8. 劉佳, 鐘璐, 朱堅軼, 等. 系統性紅斑狼瘡合并急性髓系白血病一例[J]. 白血病·淋巴瘤, 2012, 21(6):378-379.
9. Ziakas PD, Giannouli S, Zintzaras E, et al. Lupus thrombocytopenia:clinical implications and prognostic significance[J]. Ann Rheum Dis, 2005, 64(9):1366-1369.